ERD

PROCRYSTAL | Crystallisation towards efficient and sustainable biomanufacturing

01-01-2025

-

31-12-2028

Show more information

Organisation JANSSEN PHARMACEUTICA NV

EBiSC2 | EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells

01-03-2019

-

28-02-2023

Show more information

Organisation JANSSEN PHARMACEUTICA NV

AMYPAD | Amyloid imaging to Prevent Alzheimer’s Disease – Sofia ref.: 115952

01-10-2016

-

30-09-2022

Show more information

Organisation JANSSEN PHARMACEUTICA NV

CompBioMed | A Centre of Excellence in Computational Biomedicine

01-10-2016

-

30-09-2019

Show more information

Organisation JANSSEN PHARMACEUTICA NV

MiEL | Doctoral network for microprocess engineering for electrosynthesis - new synthesis concepts for pharmaceutical/ fine chemical industry

01-01-2023

-

31-12-2026

Show more information

Organisation JANSSEN PHARMACEUTICA NV

ECOTRON | How to minimize the ecological footprint for functional electronics?

01-09-2022

-

31-08-2026

Show more information

Organisation JANSSEN PHARMACEUTICA NV

ADAPTED | Alzheimers Disease Apolipoprotein Pathology for Treatment Elucidation and Development - Sofia ref.: 115975

01-10-2016

-

30-09-2020

Show more information

Organisation JANSSEN PHARMACEUTICA NV

REALMENT | Using real-world big data from eHealth, biobanks and national registries, integrated with clinical trial data to improve outcome of severe mental disorders

01-06-2021

-

30-11-2025

Show more information

Organisation JANSSEN PHARMACEUTICA NV

ALLODD | Allostery in Drug Discovery

01-09-2021

-

31-08-2025

Show more information

Organisation JANSSEN PHARMACEUTICA NV

MELLODDY | MachinE Learning Ledger Orchestration for Drug DiscoverY

01-06-2019

-

31-05-2022

Show more information

Organisation JANSSEN PHARMACEUTICA NV

M-GATE | Memory research: Ground-breaking, Applied, and Technological Exchanges

01-10-2017

-

31-03-2022

Show more information

Organisation JANSSEN PHARMACEUTICA NV

PEARRL | Pharmaceutical Education And Research with Regulatory Links: Innovative drug development strategies and regulatory tools tailored to facilitate earlier access to medicines

01-05-2016

-

31-08-2020

Show more information

Organisation JANSSEN PHARMACEUTICA NV

NEURONET | Efficiently Networking European Neurodegeneration Research

01-03-2019

-

31-08-2022

Show more information

Organisation JANSSEN PHARMACEUTICA NV

ModLife | Advancing Modelling for Process-Product Innovation, Optimization, Monitoring and Control in Life Science Industries

01-11-2015

-

31-10-2019

Show more information

Organisation JANSSEN PHARMACEUTICA NV

SCORE | Swift COronavirus therapeutics REsponse

01-04-2020

-

30-09-2022

Show more information

Organisation JANSSEN PHARMACEUTICA NV

NextBase | Base metal-catalytic cross-coupling methodologies towards sustainability

01-10-2023

-

30-09-2027

Show more information

Organisation JANSSEN PHARMACEUTICA NV

GENEGUT | Oral delivery of encapsulated RNA nanotherapeutics for targeted treatment of ileal Crohn's disease

01-10-2022

-

30-09-2026

Show more information

Organisation JANSSEN PHARMACEUTICA NV

InPharma | A fully integrated, animal-free, end-to-end modelling approach to oral drug product development

01-01-2021

-

31-12-2024

Show more information

Organisation JANSSEN PHARMACEUTICA NV

H-CCAT | Solid Catalysts for activation of aromatic C-H bonds

01-01-2017

-

30-06-2021

Show more information

Organisation JANSSEN PHARMACEUTICA NV

COMBINE | Collaboration for Prevention and Treatment of MDR Bacterial Infections

01-11-2019

-

31-10-2025

Show more information

Organisation JANSSEN PHARMACEUTICA NV

PAT4Nano | Process Analytical Technology Tools for Real-Time Physical and Chemical Characterization of Nanosuspensions

01-05-2020

-

31-10-2023

Show more information

Organisation JANSSEN PHARMACEUTICA NV

ExCAPE | Exascale Compound Activity Prediction Engine

01-09-2015

-

31-08-2018

Show more information

Organisation JANSSEN PHARMACEUTICA NV

IDEAS | Improving Design, Evaluation and Analysis of early drug development Studies

01-01-2015

-

31-12-2018

Show more information

Organisation JANSSEN PHARMACEUTICA NV

COLOTAN | Boosting advanced doctoral training in innovative colon targeting drugs

01-01-2021

-

31-12-2024

Show more information

Organisation JANSSEN PHARMACEUTICA NV

CTCAN | Clinical Trials Community Africa Network

01-05-2023

-

31-10-2025

Show more information

Organisation JANSSEN PHARMACEUTICA NV

SyDAD | Synaptic Dysfunction in Alzheimer Disease

01-11-2015

-

31-10-2019

Show more information

Organisation JANSSEN PHARMACEUTICA NV

RM ROADMAP | CREATING FRAMEWORK CONDITIONS FOR RESEARCH MANAGEMENT TO STRENGTHEN THE EUROPEAN RESEARCH AREA

01-09-2022

-

31-08-2025

Show more information

Organisation JANSSEN PHARMACEUTICA NV

EBODAC | Communication strategy and tools for optimizing the impact of Ebola vaccination deployment – Sofia ref.: 115847

01-12-2014

-

30-11-2020

Show more information

Organisation JANSSEN PHARMACEUTICA NV

DRUGtrain | Drug repurposing and discovery multidisciplinary training network

01-01-2021

-

31-12-2024

Show more information

Organisation JANSSEN PHARMACEUTICA NV

RespiriTB | Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors

01-05-2019

-

30-04-2027

Show more information

Organisation JANSSEN PHARMACEUTICA NV

Projects overview

Selected filters:

PROCRYSTAL | Crystallisation towards efficient and sustainable biomanufacturing

EBiSC2 | EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells

AMYPAD | Amyloid imaging to Prevent Alzheimer’s Disease – Sofia ref.: 115952

CompBioMed | A Centre of Excellence in Computational Biomedicine

MiEL | Doctoral network for microprocess engineering for electrosynthesis - new synthesis concepts for pharmaceutical/ fine chemical industry

ECOTRON | How to minimize the ecological footprint for functional electronics?

ADAPTED | Alzheimers Disease Apolipoprotein Pathology for Treatment Elucidation and Development - Sofia ref.: 115975

REALMENT | Using real-world big data from eHealth, biobanks and national registries, integrated with clinical trial data to improve outcome of severe mental disorders

ALLODD | Allostery in Drug Discovery

MELLODDY | MachinE Learning Ledger Orchestration for Drug DiscoverY

M-GATE | Memory research: Ground-breaking, Applied, and Technological Exchanges

PEARRL | Pharmaceutical Education And Research with Regulatory Links: Innovative drug development strategies and regulatory tools tailored to facilitate earlier access to medicines

NEURONET | Efficiently Networking European Neurodegeneration Research

ModLife | Advancing Modelling for Process-Product Innovation, Optimization, Monitoring and Control in Life Science Industries

SCORE | Swift COronavirus therapeutics REsponse

NextBase | Base metal-catalytic cross-coupling methodologies towards sustainability

GENEGUT | Oral delivery of encapsulated RNA nanotherapeutics for targeted treatment of ileal Crohn's disease

InPharma | A fully integrated, animal-free, end-to-end modelling approach to oral drug product development

H-CCAT | Solid Catalysts for activation of aromatic C-H bonds

COMBINE | Collaboration for Prevention and Treatment of MDR Bacterial Infections

PAT4Nano | Process Analytical Technology Tools for Real-Time Physical and Chemical Characterization of Nanosuspensions

ExCAPE | Exascale Compound Activity Prediction Engine

IDEAS | Improving Design, Evaluation and Analysis of early drug development Studies

COLOTAN | Boosting advanced doctoral training in innovative colon targeting drugs

CTCAN | Clinical Trials Community Africa Network

SyDAD | Synaptic Dysfunction in Alzheimer Disease

RM ROADMAP | CREATING FRAMEWORK CONDITIONS FOR RESEARCH MANAGEMENT TO STRENGTHEN THE EUROPEAN RESEARCH AREA

EBODAC | Communication strategy and tools for optimizing the impact of Ebola vaccination deployment – Sofia ref.: 115847

DRUGtrain | Drug repurposing and discovery multidisciplinary training network

RespiriTB | Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors